Listed

Arcadia Biosciences, Inc.

RKDANasdaqCIK 1469443EnergyFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.4m, Q2 FY2026
Operating income−$496.0k, Q2 FY2026
Net income−$6.3m, Q2 FY2026
Arcadia Biosciences, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k1,298Revenue, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure777Revenue, Q4 FY2023, three months to 2023-12-31$777.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-25, accession 0000950170-25-044487. Derived: 12-month figure less the 9-month figure.Report this figure987Revenue, Q1 FY2024, three months to 2024-03-31$987.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure1,306Revenue, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure1,537Revenue, Q3 FY2024, three months to 2024-09-30$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure1,216Revenue, Q4 FY2024, three months to 2024-12-31$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure1,200Revenue, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure1,455Revenue, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure1,302Revenue, Q3 FY2025, three months to 2025-09-30$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure901Revenue, Q4 FY2025, three months to 2025-12-31$901.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure1,100Revenue, Q1 FY2026, three months to 2026-03-31$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure1,443Revenue, Q2 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Cost of revenue$k818Cost of revenue, Q3 FY2023, three months to 2023-09-30$818.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure178Cost of revenue, Q4 FY2023, three months to 2023-12-31$178.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-25, accession 0000950170-25-044487. Derived: 12-month figure less the 9-month figure.Report this figure471Cost of revenue, Q1 FY2024, three months to 2024-03-31$471.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure633Cost of revenue, Q2 FY2024, three months to 2024-06-30$633.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure1,032Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure827Cost of revenue, Q4 FY2024, three months to 2024-12-31$827.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure682Cost of revenue, Q1 FY2025, three months to 2025-03-31$682.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure824Cost of revenue, Q2 FY2025, three months to 2025-06-30$824.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure884Cost of revenue, Q3 FY2025, three months to 2025-09-30$884.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure709Cost of revenue, Q4 FY2025, three months to 2025-12-31$709.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure700Cost of revenue, Q1 FY2026, three months to 2026-03-31$700.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure812Cost of revenue, Q2 FY2026, three months to 2026-06-30$812.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Research and development$k15.0Research and development, Q3 FY2023, three months to 2023-09-30$15.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure9.0Research and development, Q4 FY2023, three months to 2023-12-31$9.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-25, accession 0000950170-25-044487. Derived: 12-month figure less the 9-month figure.Report this figure6.0Research and development, Q1 FY2024, three months to 2024-03-31$6.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure10.0Research and development, Q2 FY2024, three months to 2024-06-30$10.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure24.0Research and development, Q3 FY2024, three months to 2024-09-30$24.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure13.0Research and development, Q4 FY2024, three months to 2024-12-31$13.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure0.0Research and development, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure9.0Research and development, Q2 FY2025, three months to 2025-06-30$9.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure0.0Research and development, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure0.0Research and development, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Research and development, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Selling, general and administrative$k1,862Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure1,699Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-25, accession 0000950170-25-044487. Derived: 12-month figure less the 9-month figure.Report this figure2,062Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure2,683Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$2.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure2,241Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure2,655Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$2.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure1,738Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure2,123Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure1,570Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure1,567Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure1,179Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure1,127Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Operating income$k(1,397)Operating income, Q3 FY2023, three months to 2023-09-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure(1,193)Operating income, Q4 FY2023, three months to 2023-12-31−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044487. Derived: 12-month figure less the 9-month figure.Report this figure(1,588)Operating income, Q1 FY2024, three months to 2024-03-31−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure1,980Operating income, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure(1,760)Operating income, Q3 FY2024, three months to 2024-09-30−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure(2,279)Operating income, Q4 FY2024, three months to 2024-12-31−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure530Operating income, Q1 FY2025, three months to 2025-03-31$530.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(501)Operating income, Q2 FY2025, three months to 2025-06-30−$501.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure(1,152)Operating income, Q3 FY2025, three months to 2025-09-30−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure(1,375)Operating income, Q4 FY2025, three months to 2025-12-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure(779)Operating income, Q1 FY2026, three months to 2026-03-31−$779.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(496)Operating income, Q2 FY2026, three months to 2026-06-30−$496.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$k0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure7.0Income tax, Q4 FY2023, three months to 2023-12-31$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-25, accession 0000950170-25-044487. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-13, accession 0000950170-24-096439.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure8.0Income tax, Q4 FY2024, three months to 2024-12-31$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(2,567)Net income, Q3 FY2023, three months to 2023-09-30−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure(2,853)Net income, Q4 FY2023, three months to 2023-12-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044487. Derived: 12-month figure less the 9-month figure.Report this figure(2,423)Net income, Q1 FY2024, three months to 2024-03-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure1,061Net income, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure(1,612)Net income, Q3 FY2024, three months to 2024-09-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure(4,064)Net income, Q4 FY2024, three months to 2024-12-31−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure2,599Net income, Q1 FY2025, three months to 2025-03-31$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(4,458)Net income, Q2 FY2025, three months to 2025-06-30−$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure856Net income, Q3 FY2025, three months to 2025-09-30$856.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure(1,336)Net income, Q4 FY2025, three months to 2025-12-31−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure(4,385)Net income, Q1 FY2026, three months to 2026-03-31−$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(6,266)Net income, Q2 FY2026, three months to 2026-06-30−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Diluted EPS$ per share(1.89)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figurenot reported(1.78)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure0.78Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure(1.18)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figurenot reported1.90Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(3.26)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$3.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure0.62Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figurenot reported(2.11)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$2.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(2.09)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$2.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Basic EPS$ per share(1.89)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.89 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figurenot reported(1.78)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.78 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure0.78Basic EPS, Q2 FY2024, three months to 2024-06-30$0.78 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure(1.18)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figurenot reported1.90Basic EPS, Q1 FY2025, three months to 2025-03-31$1.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(3.26)Basic EPS, Q2 FY2025, three months to 2025-06-30−$3.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure0.63Basic EPS, Q3 FY2025, three months to 2025-09-30$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figurenot reported(2.11)Basic EPS, Q1 FY2026, three months to 2026-03-31−$2.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(2.09)Basic EPS, Q2 FY2026, three months to 2026-06-30−$2.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure

Balance sheet

Cash and equivalents$4.2m, Q2 FY2026
Shareholders' equity$633.0k, Q2 FY2026
Arcadia Biosciences, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m10.6Cash and equivalents, Q3 FY2023, at 2023-09-30$10.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-062216.Report this figure6.5Cash and equivalents, FY2023, at 2023-12-31$6.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-25, accession 0000950170-25-044487.Report this figure3.3Cash and equivalents, Q1 FY2024, at 2024-03-31$3.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0000950170-24-058563.Report this figure5.5Cash and equivalents, Q2 FY2024, at 2024-06-30$5.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0000950170-24-096439.Report this figure3.9Cash and equivalents, Q3 FY2024, at 2024-09-30$3.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure4.2Cash and equivalents, FY2024, at 2024-12-31$4.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-26, accession 0001193125-26-126238.Report this figure3.2Cash and equivalents, Q1 FY2025, at 2025-03-31$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure1.4Cash and equivalents, Q2 FY2025, at 2025-06-30$1.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure1.1Cash and equivalents, Q3 FY2025, at 2025-09-30$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure0.3Cash and equivalents, FY2025, at 2025-12-31$259.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure1.0Cash and equivalents, Q1 FY2026, at 2026-03-31$954.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure4.2Cash and equivalents, Q2 FY2026, at 2026-06-30$4.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Current assets$m20.0Current assets, Q3 FY2023, at 2023-09-30$20.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062216.Report this figure15.0Current assets, FY2023, at 2023-12-31$15.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-25, accession 0000950170-25-044487.Report this figure11.6Current assets, Q1 FY2024, at 2024-03-31$11.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058563.Report this figure12.4Current assets, Q2 FY2024, at 2024-06-30$12.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096439.Report this figure10.7Current assets, Q3 FY2024, at 2024-09-30$10.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure9.2Current assets, FY2024, at 2024-12-31$9.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-26, accession 0001193125-26-126238.Report this figure8.8Current assets, Q1 FY2025, at 2025-03-31$8.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure7.6Current assets, Q2 FY2025, at 2025-06-30$7.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure8.4Current assets, Q3 FY2025, at 2025-09-30$8.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure6.4Current assets, FY2025, at 2025-12-31$6.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure5.2Current assets, Q1 FY2026, at 2026-03-31$5.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure5.7Current assets, Q2 FY2026, at 2026-06-30$5.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Total assets$m23.5Total assets, Q3 FY2023, at 2023-09-30$23.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062216.Report this figure19.7Total assets, FY2023, at 2023-12-31$19.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-25, accession 0000950170-25-044487.Report this figure16.0Total assets, Q1 FY2024, at 2024-03-31$16.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0000950170-24-058563.Report this figure17.4Total assets, Q2 FY2024, at 2024-06-30$17.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096439.Report this figure15.2Total assets, Q3 FY2024, at 2024-09-30$15.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure13.5Total assets, FY2024, at 2024-12-31$13.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-26, accession 0001193125-26-126238.Report this figure13.0Total assets, Q1 FY2025, at 2025-03-31$13.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure7.8Total assets, Q2 FY2025, at 2025-06-30$7.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure8.6Total assets, Q3 FY2025, at 2025-09-30$8.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure6.5Total assets, FY2025, at 2025-12-31$6.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure5.3Total assets, Q1 FY2026, at 2026-03-31$5.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure5.9Total assets, Q2 FY2026, at 2026-06-30$5.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Current liabilities$m3.9Current liabilities, Q3 FY2023, at 2023-09-30$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062216.Report this figure3.6Current liabilities, FY2023, at 2023-12-31$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-25, accession 0000950170-25-044487.Report this figure2.9Current liabilities, Q1 FY2024, at 2024-03-31$2.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058563.Report this figure2.7Current liabilities, Q2 FY2024, at 2024-06-30$2.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096439.Report this figure2.3Current liabilities, Q3 FY2024, at 2024-09-30$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure2.6Current liabilities, FY2024, at 2024-12-31$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001193125-26-126238.Report this figure2.2Current liabilities, Q1 FY2025, at 2025-03-31$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure1.8Current liabilities, Q2 FY2025, at 2025-06-30$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure2.3Current liabilities, Q3 FY2025, at 2025-09-30$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure2.1Current liabilities, FY2025, at 2025-12-31$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure1.4Current liabilities, Q1 FY2026, at 2026-03-31$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure1.6Current liabilities, Q2 FY2026, at 2026-06-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Total liabilities$m8.1Total liabilities, Q3 FY2023, at 2023-09-30$8.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062216.Report this figure7.0Total liabilities, FY2023, at 2023-12-31$7.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-25, accession 0000950170-25-044487.Report this figure5.6Total liabilities, Q1 FY2024, at 2024-03-31$5.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0000950170-24-058563.Report this figure5.8Total liabilities, Q2 FY2024, at 2024-06-30$5.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-096439.Report this figure5.1Total liabilities, Q3 FY2024, at 2024-09-30$5.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure7.3Total liabilities, FY2024, at 2024-12-31$7.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001193125-26-126238.Report this figure4.1Total liabilities, Q1 FY2025, at 2025-03-31$4.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure3.3Total liabilities, Q2 FY2025, at 2025-06-30$3.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure3.1Total liabilities, Q3 FY2025, at 2025-09-30$3.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure2.4Total liabilities, FY2025, at 2025-12-31$2.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure2.4Total liabilities, Q1 FY2026, at 2026-03-31$2.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure5.3Total liabilities, Q2 FY2026, at 2026-06-30$5.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m15.5Shareholders' equity, Q3 FY2023, at 2023-09-30$15.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-09, accession 0000950170-23-062216.Report this figure12.8Shareholders' equity, FY2023, at 2023-12-31$12.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-25, accession 0000950170-25-044487.Report this figure10.6Shareholders' equity, Q1 FY2024, at 2024-03-31$10.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-13, accession 0000950170-24-058563.Report this figure11.7Shareholders' equity, Q2 FY2024, at 2024-06-30$11.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-13, accession 0000950170-24-096439.Report this figure10.3Shareholders' equity, Q3 FY2024, at 2024-09-30$10.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure6.2Shareholders' equity, FY2024, at 2024-12-31$6.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-25, accession 0000950170-25-044487.Report this figure8.9Shareholders' equity, Q1 FY2025, at 2025-03-31$8.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure4.5Shareholders' equity, Q2 FY2025, at 2025-06-30$4.5m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure5.4Shareholders' equity, Q3 FY2025, at 2025-09-30$5.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure4.1Shareholders' equity, FY2025, at 2025-12-31$4.1m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure2.9Shareholders' equity, Q1 FY2026, at 2026-03-31$2.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure0.6Shareholders' equity, Q2 FY2026, at 2026-06-30$633.0k. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure

Cash flow

Operating cash flow−$319.0k, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Arcadia Biosciences, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(2,885)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125613. Derived: 9-month figure less the 6-month figure.Report this figure(4,145)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-25, accession 0000950170-25-044487. Derived: 12-month figure less the 9-month figure.Report this figure(3,210)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure(2,456)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-109040. Derived: 6-month figure less the 3-month figure.Report this figure(1,752)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272375. Derived: 9-month figure less the 6-month figure.Report this figure(2,209)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure(1,588)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(2,033)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349205. Derived: 6-month figure less the 3-month figure.Report this figure(257)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$257.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272375. Derived: 9-month figure less the 6-month figure.Report this figure(822)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$822.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349205. Derived: 12-month figure less the 9-month figure.Report this figure(1,099)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure(319)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$319.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349205. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125613. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-25, accession 0000950170-25-044487. Derived: 12-month figure less the 9-month figure.Report this figure13.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure3.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0000950170-25-109040. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272375. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0000950170-25-109040. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272375. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001193125-26-126238. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)2.99m, Q2 FY2026
Arcadia Biosciences, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares614Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30613,814 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062216.Report this figure864Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31864,391 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0000950170-24-058563.Report this figure1,358Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,358,395 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096439.Report this figure1,360Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,359,511 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125613.Report this figure1,362Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,361,657 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066425.Report this figure1,363Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,362,840 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-109040.Report this figure1,364Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,363,753 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure1,366Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,366,203 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure1,367Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,367,040 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure1,372Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,371,879 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272375.Report this figure2,083Diluted shares (weighted), Q1 FY2026, three months to 2026-03-312,082,887 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-223990.Report this figure2,993Diluted shares (weighted), Q2 FY2026, three months to 2026-06-302,992,555 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure

Shares outstanding: 2.41mShares outstanding, period not labelled, at 2026-08-062,409,211 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349205.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.